InterCure Ltd. (INCR) Stock Analysis & Investment Frameworks
InterCure Ltd. (INCR) stock analysis on Invetso. Review InterCure Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
InterCure Ltd. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: IL
InterCure Ltd. Key Financial Metrics
- Market Cap: $39.03M
- Revenue: $84.30M
- ROE: -8.54%
- ROIC: -5.19%
- Dividend Yield: N/A
About InterCure Ltd.
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
InterCure Ltd. Investment Frameworks
Invetso analyzes InterCure Ltd. (INCR) across the following frameworks:
- InterCure Ltd. 10Y Growth Potential
- InterCure Ltd. Scenario Analysis
- InterCure Ltd. Risks & Opportunities
- InterCure Ltd. Economic Moat
- InterCure Ltd. Business Model
- InterCure Ltd. Management
- InterCure Ltd. SWOT Analysis
- InterCure Ltd. Porter's 5 Forces
- InterCure Ltd. PESTLE Analysis
- InterCure Ltd. ESG Analysis